Jill Feldman: Excited to participate in the 4th Annual End Lung Cancer Now Gathering
Jill Feldman posted on X:
“I am excited to participate in the 4th Annual End Lung Cancer Now Gathering!
The theme of this year’s Gathering is Research Cures Cancer, and the goal is to educate about the importance of research and empower patients and advocates.
Join us November 8th, 8 am – 1 pm at the NCAA Hall of Champions.
I will proudly represent Kansas Men’s Basketball.”
Source: Jill Feldman/X
Jill Feldman is a lung cancer patient and advocate. She is the Co-Founder EGFR Resisters, an advocacy group of EGFR positive lung cancer patients who are resistant to targeted treatment. She is the Past President of the LUNGevity Foundation, Deputy Chair of IASLC’s patient advisory board and a member of The Chicago Institute of Translational Medicine’s patient advisory board.
Jill is a member of the programmatic panel for the Department of Defense Lung Cancer Research Program, a planning committee member on IASLC’s North America Conference on Lung cancer and as a member of the the ECOG-ACRIN Research Group’s patient advocate committee and thoracic committee.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023